Notably, the majority of genes that were significantly downregulated in patients who had a good TB treatment outcome, but not in patients who had a poor TB treatment outcome, are involved in IFN signaling (IRF7, IFIT2, IFIT3, STAT2, IFI6, TAP2). The gene discussed is TAP2; the disease is tuberculosis.